BioLife Solutions (NASDAQ: BLFS) reported Q4 EPS of ($0.30), $0.04 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $32.7 million versus the consensus estimate of $33.4 million.

GUIDANCE:

BioLife Solutions sees FY2024 revenue of $95.5-100 million, versus the consensus of $106.3 million.

For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.